Wells Fargo
DMK

Wells Fargo’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wells Fargo’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-214
Closed -$149 – 7808
2023
Q4 		$149 Buy
214
+11
+5% +$6 ﹤0.01% 6673
2023
Q3 		$140 Buy
203
+44
+28% +$56 ﹤0.01% 6676
2023
Q2 		$383 Buy
159
+1
+0.6% +$4 ﹤0.01% 6542
2023
Q1 		$1.28K Buy
158
+143
+953% +$1.9K ﹤0.01% 6315
2022
Q4 		$173 Buy
15
+1
+7% +$11 ﹤0.01% 6665
2022
Q3 		$0 Hold
14
– – ﹤0.01% 7653
2022
Q2 		$1K Buy
14
+1
+8% +$31 ﹤0.01% 6668
2022
Q1 		$1K Hold
13
– – ﹤0.01% 6896
2021
Q4 		$1K Hold
13
– – ﹤0.01% 7110
2021
Q3 		$1K Sell
13
-1
-7% -$73 ﹤0.01% 6847
2021
Q2 		$1K Buy
14
+2
+17% +$122 ﹤0.01% 6782
2021
Q1 		$1K Buy
12
+3
+33% +$234 ﹤0.01% 6793
2020
Q4 		$0 Buy
9
+3
+50% +$133 ﹤0.01% 7204
2020
Q3 		$0 Sell
6
-1
-14% -$59 ﹤0.01% 7096
2020
Q2 		$0 Buy
7
+1
+17% +$34 ﹤0.01% 6999
2020
Q1 		$0 Sell
6
-21
-78% -$891 ﹤0.01% 7001
2019
Q4 		$1K Sell
27
-758
-97% -$36.7K ﹤0.01% 6293
2019
Q3 		$39K Sell
785
-28
-3% -$2.01K ﹤0.01% 5632
2019
Q2 		$74K Buy
813
+80
+11% +$9.73K ﹤0.01% 5422
2019
Q1 		$108K Sell
733
-34
-4% -$6.57K ﹤0.01% 5104
2018
Q4 		$121K Buy
767
+318
+71% +$61K ﹤0.01% 5198
2018
Q3 		$110K Sell
449
-84
-16% -$19.9K ﹤0.01% 5318
2018
Q2 		$120K Buy
533
+131
+33% +$35.1K ﹤0.01% 5303
2018
Q1 		$98K Sell
402
-1
-0.2% -$262 ﹤0.01% 5310
2017
Q4 		$124K Buy
403
+368
+1,051% +$121K ﹤0.01% 5217
2017
Q3 		$13K Sell
35
-429
-92% -$152K ﹤0.01% 5817
2017
Q2 		$169K Buy
+464
New +$139K ﹤0.01% 4888
2017
Q1 		– Sell
-43
Closed -$9K – 6569
2016
Q4 		$9K Buy
+43
New +$8.62K ﹤0.01% 5841
2015
Q1 		– Sell
-3
Closed -$1K – 6417
2014
Q4 		$1K Buy
+3
New +$953 ﹤0.01% 6117

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Wells Fargo's DMK Position: Q1 2024 in Review

Wells Fargo sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 214 shares — an estimated $149 sold.

Wells Fargo first reported a position in DMK in Q4 2014 and held it in 29 quarters. The position peaked at $169K in Q2 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Wells Fargo reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 214 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $149.
  • Wells Fargo first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2014 and held it in 29 quarters.
  • Wells Fargo's DMK Pharmaceuticals Corporation Common Stock position peaked at $169K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.